GOLDMAN SACHS GROUP INC - PRINCIPIA BIOPHARMA INC ownership

PRINCIPIA BIOPHARMA INC's ticker is PRNB and the CUSIP is 74257L108. A total of 54 filers reported holding PRINCIPIA BIOPHARMA INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 1.7%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of PRINCIPIA BIOPHARMA INC
ValueSharesWeighting
Q2 2020$22,345,000
+202.6%
373,720
+200.5%
0.01%
+250.0%
Q1 2020$7,385,000
+121.0%
124,355
+103.8%
0.00%
+100.0%
Q4 2019$3,342,000
+299.8%
61,014
+106.2%
0.00%
Q3 2019$836,000
+209.6%
29,585
+263.8%
0.00%
Q2 2019$270,000
-1.1%
8,132
+1.3%
0.00%
Q1 2019$273,000
-18.8%
8,027
-34.5%
0.00%
Q4 2018$336,000
-85.2%
12,253
-84.3%
0.00%
-100.0%
Q3 2018$2,276,00077,8960.00%
Other shareholders
PRINCIPIA BIOPHARMA INC shareholders Q4 2018
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 342,946$20,505,0006.60%
BVF INC/IL 1,484,674$88,769,0005.47%
Sofinnova Investments, Inc. 1,417,258$84,738,0005.34%
New Leaf Venture Partners, L.L.C. 249,774$14,934,0004.28%
Cormorant Asset Management, LP 1,590,493$95,096,0003.63%
Redmile Group, LLC 2,712,388$162,174,0002.99%
Avidity Partners Management LP 548,500$32,795,0002.10%
Logos Global Management LP 150,000$8,969,0001.79%
Boxer Capital, LLC 607,000$36,293,0001.60%
Woodline Partners LP 318,677$19,054,0000.76%
View complete list of PRINCIPIA BIOPHARMA INC shareholders